Clinical trial
Early Antiviral Responses to Rhinovirus Infection in Asthma
NCT05050903 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Antiviral Responses to Rhinovirus Infection in Asthma
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 11, 2022
- Completion date
- August 31, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.